Avalon Care Center at Northpointe gave Resident 1 less than their prescribed 70mg daily methadone dose from April 1 through April 12, 2025, federal inspectors found. The facility skipped the dose entirely on April 8 when the resident attended an appointment at their opioid treatment program.
The deception unraveled in late May when staff at the opioid treatment program examined returned medication vials that should have been empty. Instead, they found "dose amounts remaining" in multiple containers.
"The facility did not report giving the resident less methadone than ordered by the OTP until the OTP staff asked about the remaining dose amounts," Collateral Contact 1 told inspectors on May 30.
Administrator Staff D acknowledged during a July interview that the facility had no specific policies for residents receiving treatment at opioid programs. The administrator claimed they followed the treatment program's orders but said Resident 1's case was "difficult" because hospital doctors and other medical providers expressed concerns about combining methadone with the resident's other medical conditions.
Medical records show the complexity Staff D described. A provider progress note from April 2 indicated Resident 1 should continue receiving 70mg of methadone daily, with Staff B scheduled to follow up about hepatology team recommendations over the next several days.
But inspectors found no documentation that anyone at the nursing home consulted the opioid treatment program about changing the methadone dose or attempted to coordinate care between the treatment program's medical providers and the resident's hepatology specialists.
Staff B was unavailable for interviews during the inspection.
The facility's Medical Director Staff C, who was not in that role during April 2025, explained the confusion over who controls methadone dosing. If methadone treats pain, facility providers can adjust doses. But if the medication treats opioid use disorder, residents should go to the opioid treatment program for dosing decisions.
"If there were multiple types of providers involved in a resident's care who disagreed on treatment, they would coordinate with the various providers directly," Staff C told inspectors on September 17.
The case highlights the dangerous gaps that can emerge when nursing homes treat residents receiving medication-assisted treatment for opioid addiction. Methadone requires precise dosing - too little can trigger withdrawal symptoms and cravings that drive people back to illicit drug use, while coordination failures can create medical complications.
Resident 1's treatment involved multiple medical teams with potentially conflicting priorities. The opioid treatment program prescribed 70mg daily to maintain recovery from addiction. Meanwhile, hepatology specialists raised concerns about drug interactions with the resident's liver condition.
Rather than coordinate between the specialists, nursing home staff made unilateral dosing decisions without informing the treatment program. They reduced or eliminated doses for eleven days while the opioid treatment program believed their patient was receiving full prescribed amounts.
The facility's lack of specific policies for opioid treatment program patients meant staff operated without clear protocols for these complex cases. Administrator Staff D's admission that they had no relevant policies suggests other residents receiving addiction treatment could face similar coordination failures.
Federal regulations require nursing homes to ensure residents receive medications as prescribed and to coordinate care among multiple providers. The inspection found Avalon Care Center failed on both requirements.
The timing of the discovery added another layer of concern. The opioid treatment program only noticed the dosing discrepancies when examining returned vials in late May - more than a month after the unauthorized dose reductions ended. This delay suggests the facility might have continued the practice indefinitely without external detection.
For Resident 1, the reduced methadone doses came during a critical period when hepatology specialists were making treatment recommendations. The resident needed coordinated care between addiction medicine and liver specialists, but instead received fragmented treatment that left them vulnerable to both withdrawal symptoms and medical complications.
The case illustrates broader challenges facing nursing homes as the opioid crisis drives more residents with addiction histories into long-term care. These patients require specialized knowledge about medication-assisted treatment that many facilities lack.
Staff C's explanation about different dosing authorities for pain versus addiction treatment reveals the complexity. But complexity doesn't excuse the fundamental failure to communicate with the opioid treatment program about dose changes that could have triggered life-threatening withdrawal.
Resident 1 spent nearly two weeks receiving inadequate addiction treatment while their nursing home and opioid treatment program operated under completely different assumptions about their care. Only the treatment program's diligence in checking returned vials exposed the deception that left a recovering patient at risk.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avalon Care Center At Northpointe from 2025-09-17 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Avalon Care Center At Northpointe
- Browse all WA nursing home inspections